Palivizumab (Synagis) is indicated for the prevention of serious lower respiratory tract disease requiring hospitalization caused by respiratory syncytial virus
Aim is to treat Dyslipidemia by inhibiting PCSK9 with a novel entity
Dr. Karikó is the third Solvay Prize winner to become a Nobel Prize laureate
New Board of Directors and management team at Suven Pharma also appointed
Education on Inhalation Therapy & Conducting Nationwide Awareness Camps, Alkem Breathe Initiative Addresses the Alarming Increase in Respiratory Diseases in India
‘Sanjeevani’ aims to raise awareness and encourage conversations around the silent cancer epidemic
Also to be launched Scheme for promotion of Research and Innovation in Pharma MedTech Sector (PRIP)
India is promoting holistic healthcare with emphasis on preventive care
National Health Authority (NHA) to host the two-day Arogya Manthan event in New Delhi
Dr. Jitendra Singh inaugurates 300 LPM capacity Oxygen Plant, Day Care Chemotherapy Unit affiliated to Tata Memorial Hospital & Maternal ICU at GMC Kathua
Subscribe To Our Newsletter & Stay Updated
